FDA Approved: PRASUGREL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for prasugrel from Aurobindo Pharma Limited, enabling a generic version of the antiplatelet drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)